Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11548870 Compounds useful as inhibitors of helios protein

Patent 11548870 was granted and assigned to Bristol-Myers Squibb on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

115488700

Patent Inventor Names

Andrew P. Degnan0

James Aaron Balog0

Guo Li0

Godwin Kwame Kumi0

Audris Huang0

Ashok Vinayak Purandare0

Weifang Shan0

Date of Patent

January 10, 2023

Patent Application Number

169509780

Date Filed

November 18, 2020

Patent Citations

‌

US Patent 10040804 Compounds targeting proteins, compositions, methods, and uses thereof

‌

US Patent 10669260 Compounds targeting proteins, compositions, methods, and uses thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11548870 Compounds useful as inhibitors of helios protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API